GSE128076 doxycycline HEK293 2 v 3 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE128076_doxycycline_HEK293_2_v_3_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE128076_doxycycline_HEK293_2_v_3_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE128076_doxycycline_HEK293_2_v_3_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE128076_doxycycline_HEK293_2_v_3_human_up.

Results found

Linked to

 

Label

Description

 

Gene

H2B clustered histone 8

Gene

H3 clustered histone 7

Gene

family with sequence similarity 106 member A

Gene

CENPB DNA-binding domains containing 2, pseudogene

Gene

long intergenic non-protein coding RNA 1963

Gene

long intergenic non-protein coding RNA 632

Gene

uncharacterized LOC100506076

Gene

ZNF606 antisense RNA 1

Gene

HOXC13 antisense RNA

Gene

EP400 pseudogene 1

  • Gene

    H2B clustered histone 8


  • Gene

    H3 clustered histone 7


  • Gene

    family with sequence similarity 106 member A


  • Gene

    CENPB DNA-binding domains containing 2, pseudogene


  • Gene

    long intergenic non-protein coding RNA 1963


  • Gene

    long intergenic non-protein coding RNA 632


  • Gene

    uncharacterized LOC100506076


  • Gene

    ZNF606 antisense RNA 1


  • Gene

    HOXC13 antisense RNA


  • Gene

    EP400 pseudogene 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.